These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2016550)

  • 1. [T1 bladder tumors. Can they be considered superficial?].
    el Ouakdi M; Njeh M; Smaoui S; Masmoudi Z; Ayed M; Zmerli S
    J Urol (Paris); 1991; 97(1):33-5. PubMed ID: 2016550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Course of superficial carcinoma of bladder (Ta-T1). Apropos of 171 cases].
    Novak R
    J Urol (Paris); 1987; 93(1):21-4. PubMed ID: 3559256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of patients with superficial bladder cancer after treatment: a 10-year retrospective follow-up study.
    Uchida K; Shimazui T; Nemoto R; Kano S; Koiso K
    Jpn J Clin Oncol; 1984 Sep; 14(3):369-77. PubMed ID: 6482017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgically treated transitional cell carcinomas of the bladder. The role of radical surgery.
    Al-Ali MA; Kashmoula DM; Haddad LF
    Saudi Med J; 2002 Jun; 23(6):695-9. PubMed ID: 12070550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histopathologic characteristics and clinical behavior of superficial bladder tumors].
    Kolozsy Z; Samodai L; Mohácsi L; Dauda G; Endresz KF
    Orv Hetil; 1990 Feb; 131(6):283-4, 287-9. PubMed ID: 2406685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
    Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
    J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surveillance and prognosis of "T1" superficial tumors of the bladder. Homogeneous series of 88 cases followed for 1 to 22 years].
    Lachand AT; Texier J; Texier P
    Prog Urol; 2001 Jun; 11(3):472-7. PubMed ID: 11512460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year.
    Guney S; Guney N; Canogullari Z; Ergenekon E
    Urol Int; 2008; 80(2):124-8. PubMed ID: 18362479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of stage Ta,T1 and Tis bladder tumors using Calmette-Guérin bacillus vaccine].
    Bretheau D; Lechevallier E; Rossi D; Albert P; de Fromont M; Coulange C
    Prog Urol; 1993; 3(4):608-17. PubMed ID: 8401621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Natural history and prognostic factors of superficial tumors of the bladder].
    Hoznek A; Bellot J; Abbou CC; Chopin DK
    Ann Urol (Paris); 1993; 27(1):20-3. PubMed ID: 8470875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for upper tract recurrence in patients undergoing long-term surveillance for stage ta bladder cancer.
    Canales BK; Anderson JK; Premoli J; Slaton JW
    J Urol; 2006 Jan; 175(1):74-7. PubMed ID: 16406874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surveillance and prognosis of "Ta" superficial tumors of the bladder. Homogeneous series of 138 cases followed for 1 to 18 years].
    Lachand AT; Texier J; Texier P
    Prog Urol; 2001 Jun; 11(3):466-71. PubMed ID: 11512459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factors affecting the recurrence rate and progression of superficial (Ta-T1) bladder tumors].
    Kondás J
    Orv Hetil; 1985 Mar; 126(10):577-80. PubMed ID: 3991152
    [No Abstract]   [Full Text] [Related]  

  • 18. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
    Divrik RT; Sahin A; Altok M; Unlü N; Zorlu F
    J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of prognostic factors in superficial bladder tumors].
    Páez Borda A; Martín Osés E; de la Cal López M; Llorente Abarca C; Berenguer Sánchez A
    Arch Esp Urol; 1997 Mar; 50(2):121-6. PubMed ID: 9206936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.